These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15834131)

  • 1. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
    Zhu B; Ramachandran B; Gulick T
    J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
    Martin JF; Miano JM; Hustad CM; Copeland NG; Jenkins NA; Olson EN
    Mol Cell Biol; 1994 Mar; 14(3):1647-56. PubMed ID: 8114702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.
    Yu YT; Breitbart RE; Smoot LB; Lee Y; Mahdavi V; Nadal-Ginard B
    Genes Dev; 1992 Sep; 6(9):1783-98. PubMed ID: 1516833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
    Molkentin JD; Black BL; Martin JF; Olson EN
    Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte enhancer factor 2A is transcriptionally autoregulated.
    Ramachandran B; Yu G; Li S; Zhu B; Gulick T
    J Biol Chem; 2008 Apr; 283(16):10318-29. PubMed ID: 18073218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA.
    Ichida M; Endo H; Ikeda U; Matsuda C; Ueno E; Shimada K; Kagawa Y
    J Biol Chem; 1998 Apr; 273(14):8492-501. PubMed ID: 9525963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors.
    McDermott JC; Cardoso MC; Yu YT; Andres V; Leifer D; Krainc D; Lipton SA; Nadal-Ginard B
    Mol Cell Biol; 1993 Apr; 13(4):2564-77. PubMed ID: 8455629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage.
    Breitbart RE; Liang CS; Smoot LB; Laheru DA; Mahdavi V; Nadal-Ginard B
    Development; 1993 Aug; 118(4):1095-106. PubMed ID: 8269842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEF2B is a potent transactivator expressed in early myogenic lineages.
    Molkentin JD; Firulli AB; Black BL; Martin JF; Hustad CM; Copeland N; Jenkins N; Lyons G; Olson EN
    Mol Cell Biol; 1996 Jul; 16(7):3814-24. PubMed ID: 8668199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
    Nguyen T; Wang J; Schulz RA
    Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity.
    Yu YT
    J Biol Chem; 1996 Oct; 271(40):24675-83. PubMed ID: 8798735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis.
    Lilly B; Galewsky S; Firulli AB; Schulz RA; Olson EN
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5662-6. PubMed ID: 8202544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
    Wu W; de Folter S; Shen X; Zhang W; Tao S
    PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
    Molkentin JD; Li L; Olson EN
    J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.
    Belaguli NS; Zhou W; Trinh TH; Majesky MW; Schwartz RJ
    Mol Cell Biol; 1999 Jul; 19(7):4582-91. PubMed ID: 10373507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment.
    Wu Y; Dey R; Han A; Jayathilaka N; Philips M; Ye J; Chen L
    J Mol Biol; 2010 Mar; 397(2):520-33. PubMed ID: 20132824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocyte enhancer factor 2 (MEF2).
    Brand NJ
    Int J Biochem Cell Biol; 1997 Dec; 29(12):1467-70. PubMed ID: 9570140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23.
    Hobson GM; Krahe R; Garcia E; Siciliano MJ; Funanage VL
    Genomics; 1995 Oct; 29(3):704-11. PubMed ID: 8575763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.